International Congress London 2016

---

PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease

Postgraduate Course
Chairs: Pierantonio Laveneziana (Paris, France), François Maltais (Quebec, Canada)
Aims: To describe the clinical importance of chronic obstructive pulmonary disease (COPD) muscle dysfunction, the risk factors, and the underlying mechanisms; to discuss the potential relationships and differences between exercise capacity and physical activity in COPD patients; to describe to what extent pulmonary rehabilitation and nutritional support may benefit patients with advanced COPD and severe comorbidities such as poor muscle function and muscle loss; to explore the mechanisms that underlie the impairment of skeletal muscle function and mass loss during acute exacerbations in COPD patients; and to describe the available strategies for treating acute exacerbation-induced muscle dysfunction and loss.

---

How to access educational materials from mobile devices

---

Programme PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease
Reading list PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease
Clinical relevance of COPD muscle dysfunction and body composition alterations, and their risk factors and underlying mechanisms Esther Barreiro Portela (Barcelona, Spain)
Differences between exercise capacity and physical activity in COPD: from the lungs to the periphery Roberto A. Rabinovich (Edinburgh, United Kingdom)
Pulmonary rehabilitation and nutritional support in COPD patients with altered body composition and poor exercise capacity Ioannis Vogiatzis (Athens, Greece)